Welcome Guest!  Login | Register | Help | Survey
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
WPI [NYSE]
Watson Pharmaceuticals Inc.
Healthcare - Drugs - Generic - USA
IndexS&P 500 P/E19.64 EPS (ttm)1.94 Insider Own1.36% Shs Outstand106.14M Perf Week-3.57%
Market Cap4.04B Forward P/E11.76 EPS next Y3.24 Insider Trans-4.63% Shs Float104.70M Perf Month-3.32%
Income221.49M PEG2.28 EPS next Q0.76 Inst Own92.58% Short Float2.57% Perf Quarter7.72%
Sales2.65B P/S1.52 EPS this Y64.56% Inst Trans1.91% Short Ratio2.89 Perf Half Y11.05%
Book/sh21.79 P/B1.75 EPS next Y17.39% ROA5.85% Target Price43.96 Perf Year33.36%
Cash/sh7.78 P/C4.90 EPS next 5Y8.63% ROE10.16% 52W Range25.31 - 42.50 Perf YTD-3.81%
Dividend- P/FCF13.63 EPS past 5Y3.76% ROI6.58% 52W High-10.35% Beta0.56
Dividend %- Quick Ratio3.14 Sales past 5Y11.71% Gross Margin43.01% 52W Low50.53% ATR0.79
Employees5070 Current Ratio4.29 Sales Q/Q3.34% Oper. Margin14.02% RSI (14)42.27 Volatility2.31% 2.06%
OptionableYes Debt/Eq0.43 EPS Q/Q-10.89% Profit Margin8.35% Rel Volume0.92 Prev Close37.69
ShortableYes LT Debt/Eq0.43 EarningsFeb 23 BMO Payout0.00% Avg Volume931.74K Price38.10
Recom2.70 SMA20-3.67% SMA50-2.34% SMA2008.38% Volume858,859 Change1.09%
22-Jan-10Downgrade Needham Hold → Underperform
11-Dec-09Initiated Piper Jaffray Underweight $34
10-Dec-09Initiated Sun Trust Rbsn Humphrey Buy $46
01-May-09Reiterated RBC Capital Mkts Outperform $37 → $39
23-Apr-09Initiated RBC Capital Mkts Outperform $37
25-Feb-09Initiated Credit Suisse Neutral
17-Feb-09Initiated Citigroup Hold $34
22-Jan-09Upgrade Stanford Research Hold → Buy $31
17-Dec-08Initiated JP Morgan Neutral
06-Nov-08Downgrade Credit Suisse Neutral → Underperform $29 → $23
25-Sep-08Initiated Stanford Research Hold
25-Sep-08Initiated Needham Hold
22-Sep-08Upgrade Wachovia Mkt Perform → Outperform
25-Feb-08Reiterated Roth Capital Buy $39 → $38
21-Feb-08Reiterated Lehman Brothers Equal-weight $35 → $33
19-Feb-08Upgrade WR Hambrecht Hold → Buy
18-Dec-07Initiated Banc of America Sec Neutral $31
28-Sep-07Upgrade Roth Capital Hold → Buy $34.50 → $39
03-Aug-07Reiterated Roth Capital Hold $31 → $34.50
02-May-07Upgrade UBS Neutral → Buy $37
04-Feb-10 05:06PM  Iron Safety Hits AMAG Pharmaceuticals at Seeking Alpha
02-Feb-10 11:18AM  Cephalon Enters Generics Market Zacks.com
08:30AM  Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook PR Newswire
01-Feb-10 12:10PM  Watson signs deal for emergency contraceptive AP
08:08AM  InPlay: Watson Pharm and HRA Pharma announced an exclusive licensing agreement Briefing.com
08:00AM  Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S. PR Newswire
29-Jan-10 09:54AM  Watson completes $15 million buyout of Eden AP
28-Jan-10 04:05PM  Watson Completes Acquisition of Eden Biodesign PR Newswire
02:30PM  The Biggest Growth Stocks in Health Care at Minyanville.com
27-Jan-10 12:15PM  Improving Visibility on Watson Zacks.com
10:44AM  There's Nothing Generic About the Profits at Investopedia
26-Jan-10 07:45AM  UPDATE - Novartis optimistic on generic Lovenox approval at Reuters
22-Jan-10 12:47PM  UPDATE - Novartis says on track with generic Lovenox at Reuters
08:25AM  Watson Pharm downgraded by Needham Briefing.com
21-Jan-10 10:18AM  UPDATE - Watson Pharma sees 2010 revs above Street view at Reuters
09:18AM  Watson Pharmaceuticals sets 2010 outlook AP
08:34AM  UPDATE - Watson sees 2010 revs above Street view at Reuters
08:00AM  WATSON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
07:53AM  Watson provides 2010 financial forecast at MarketWatch
07:45AM  Watson Provides Overview of Global Operations; Delivers Outlook for Continued Growth PR Newswire
19-Jan-10 03:28PM  Pfizer Gets Serious About Generics at Motley Fool
11:57AM  Endo faces Watson patent challenge on Lidoderm AP
11:53AM  /C O R R E C T I O N -- Watson Pharmaceuticals, Inc./ PR Newswire
11:20AM  Bid target Ratiopharm margins below average at Reuters
09:30AM  UPDATE - Endo Pharma's Lidoderm patch gets generic threat at Reuters
14-Jan-10 06:08PM  Your First Move For Friday January 15th at CNBC
05:59PM  [video] Fast Money Final Trades at CNBC
04:18PM  Watson Set to Beat Expectations Zacks.com
13-Jan-10 04:19PM  Equities Update: Earnings Hopes Boost Stocks at Seeking Alpha
01:27PM  UPDATE - Watson says 2009 profit to meet or exceed forecast at Reuters
10:54AM  Watson Pharma says 2009 profit could beat views AP
09:38AM  China Weaker, Bullishness Remains High at CNBC
08:48AM  WATSON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
08:25AM  UPDATE - Watson says 2009 profit to meet or exceed forecast at Reuters
08:16AM  Watson sees 2009 sales rising by 9% at MarketWatch
08:00AM  Watson Announces Preliminary Financial Performance for FY 2009 PR Newswire
12-Jan-10 04:30PM  Watson Pharmaceuticals to Host 'Investor Day 2010' on Thursday, January 21st in New York City Marketwire
08-Jan-10 05:27PM  Neutral on Watson Zacks.com
12:20PM  Sector Snap: Generic drugmakers downgraded AP
08:30AM  Watson Files FDA Application for Generic LoSeasonique(R) PR Newswire
07-Jan-10 05:13PM  Teva sees revenue more than doubling by 2015 Reuters
05:00PM  UPDATE - Teva sees revenue more than doubling by 2015 at Reuters
10:37AM  Cephalon's Nuvigil Under Pressure Zacks.com
06-Jan-10 02:05PM  Watson Pharmaceuticals seeking OK to sell generic version of Cephalons Nuvigil at bizjournals.com
12:15PM  Cephalon sues Watson over sleep drug Nuvigil AP
11:06AM  Watson Files FDA Application for Generic Nuvigil(R) PR Newswire
09:41AM  Cephalon sues Watson Pharma for drug patent infringement at Reuters
08:00AM  Watson to Present at 28th Annual JPMorgan Healthcare Conference PR Newswire
29-Dec-09 04:18AM  Watson Pharmaceuticals: Look-Ahead to December 2009 Quarterly Results at Seeking Alpha
22-Dec-09 02:33PM  4-Star Stocks on the Upswing at Motley Fool
03:47AM  UPDATE - Ratiopharm to beat own expectations for 2009 at Reuters
21-Dec-09 05:40PM  According To Credit Suisse Vice President, Certain Health Care Stocks To Benefit Greatly From U.S. Legislation: Which Companies Stand To Benefit The Most? Wall Street Transcript
14-Dec-09 01:15PM  [$$] A Look at the Market Leaders at RealMoney by TheStreet.com
11:55AM  Large And Small Cap Picks In The Health Care Space: Credit Suisse Analyst Guides Investors On Which Stocks Are A Good Buy Wall Street Transcript
09:04AM  Stealth Generic Drug Play: 1 Minute Trade TheStreet.com TV
08:50AM  Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy PR Newswire
07:40AM  How to Play Generic Drug Stocks at Minyanville.com
11-Dec-09 09:38AM  [video] Stealth Generic Drug Play: 1 Minute Trade at TheStreet.com
10-Dec-09 03:14PM  Equity Valuations In The Health Care Service Space Not To Be Affected By Unemployment Levels, According To BMO Analyst Wall Street Transcript
10:51AM  Biotech Stocks: Drug stocks climb; Lilly falls on forecast at MarketWatch
09-Dec-09 11:49AM  Watson Acquires Arrow Zacks.com
09:14AM  Which Health Care Sectors Will Benefit Under Impending Legislation? The Answer According To Lazard Capital Wall Street Transcript
08:50AM  New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's RAPAFLO(R) (silodosin) for Benign Prostatic Hyperplasia (BPH) Symptom Relief PR Newswire
04-Dec-09 01:14PM  Ratiopharm gets higher offers, to winnow bidders at Reuters
09:26AM  Watson challenges Takeda's Rozerem patent AP
08:30AM  Watson Files FDA Application for Generic Rozerem(R) PR Newswire
02-Dec-09 05:14PM  Impax buys applications for 2 Watson generics AP
04:44PM  WATSON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition EDGAR Online
12:42PM  Watson Completes Acquisition of Arrow Group PR Newswire
10:47AM  Watson completes $1.75 billion buyout of Arrow AP
09:15AM  Watson Completes Acquisition of Arrow Group PR Newswire
09:00AM  Watson Receives FTC Clearance for Arrow Acquisition PR Newswire
01-Dec-09 12:54PM  Better Buy: Pfizer or Teva Pharmaceutical? at Motley Fool
30-Nov-09 01:37PM  Van Berkom And Associates Prices Health Care And Industrial Companies Wall Street Transcript
27-Nov-09 11:07PM  Brand 'Biologics' Retain Edge in Bills at The Wall Street Journal Online
25-Nov-09 05:16AM  Watson Pharmaceutical Financial Gauge Analysis for the September 2009 Quarter at Seeking Alpha
23-Nov-09 09:09AM  Israel Stocks: Tel Aviv broadly higher; Israel Chemicals in focus at MarketWatch
18-Nov-09 06:50AM  StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc. GlobeNewswire
16-Nov-09 07:00AM  Watson Names Robert A. Stewart Senior Vice President, Global Operations PR Newswire
13-Nov-09 09:05AM  WATSON PHARMACEUTICALS INC Financials EDGAR Online Financials
12-Nov-09 06:07PM  Cephalon, Barr settle Fentora dispute AP
06:06PM  UPDATE - Cephalon, Barr settle patent infringement suit at Reuters
10-Nov-09 09:12PM  Watson Announces Presentation Time Change at Credit Suisse Healthcare Conference PR Newswire
08-Nov-09 11:32AM  Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter at Seeking Alpha
06:35AM  Cephalon's Upside and Downside at Seeking Alpha
06-Nov-09 04:12PM  WATSON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04:00PM  Watson to Present at Credit Suisse Healthcare Conference PR Newswire
08:30AM  Specialty Pharma Stock Picks From David Amsellem Of Piper Jaffray Wall Street Transcript
05-Nov-09 12:10PM  Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships Wall Street Transcript
12:05PM  Abraxis opens expanded plant in Phoenix, expected to create 200 jobs at bizjournals.com
09:29AM  New Star Analyst Rankings for WATSON PHARMACEUTCLS StarMine
08:54AM  Chinese Companies Traded On US Stock Exchanges Provide Deep Value For Investors According To First Wilshire Securities Wall Street Transcript
04-Nov-09 04:42PM  Watson Pharma Beats by a Penny Zacks.com
03:22PM  Watson Pharmaceuticals Q3 2009 Earnings Call Transcript at Seeking Alpha
11:49AM  RPT-UPDATE - Watson Pharma third-quarter net profit falls at Reuters
10:49AM  UPDATE - Watson Pharma third-quarter net profit falls at Reuters
10:39AM  REFILE-UPDATE - Watson Pharma third-quarter net profit falls at Reuters
09:50AM  Watson 3Q profit falls 11 percent on taxes, costs AP
08:30AM  Watson Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:08AM  UPDATE - Watson Pharma third-quarter net profit falls at Reuters
Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products primarily in the United States. The company's products are used in various therapeutic areas, including central nervous system, hormones and synthetic substitutes, cardiovascular, nephrology, gastrointestinal, and other areas. It operates in three segments: Generic, Brand, and Distribution. The Generic segment manufactures and sells generic products for various therapeutic classes comprising anti-depressant, anti-hypertensive, anti-diabetic, antiemetic, anti-hypertensive, analgesic, oral contraceptives, analgesic, and gastrointestinal areas, as well as for osteoporosis preparation and aid to smoking cessation. The Brand segment principally offers products for male hormone replacement, hematinic, overactive bladder, and prostate cancer therapeutics, as well as specialty products for urology and nephrology products for the treatment of iron deficiency anemia. The Distribution segment distributes generic and brand pharmaceutical products to independent pharmacies; alternate care providers, such as hospitals, nursing homes, and mail order pharmacies; pharmacy chains; physicians' offices; and members of buying groups. The company markets its products primarily to drug wholesalers; retailers and distributors, including national retail drug and food store chains; hospitals; clinics; mail order; and government agencies and managed healthcare providers, such as health maintenance organizations and other institutions. As of December 31, 2008, Watson Pharmaceuticals marketed approximately 150 generic pharmaceutical product families and 27 brand pharmaceutical product families, as well as distributed approximately 8,000 stock-keeping units. The company was founded in 1983 and is based in Corona, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GIORDANO THOMAS RSr VP and CIODec 16Option Exercise25.6210,000256,20033,099Dec 17 05:14 PM
GIORDANO THOMAS RSr VP and CIODec 16Sale38.4710,000384,70023,099Dec 17 05:14 PM
EBERT CHARLES DSr. VP, Research & DevelopmentDec 10Option Exercise27.2619,000517,88040,457Dec 11 04:21 PM
MIRANDA DIANE FVP,Generic Marketing & Oper.Dec 10Option Exercise28.2825,653725,46739,941Dec 11 04:26 PM
MIRANDA DIANE FVP,Generic Marketing & Oper.Dec 10Sale38.3125,653982,88814,288Dec 11 04:26 PM
EBERT CHARLES DSr. VP, Research & DevelopmentDec 10Sale38.2519,000726,75021,457Dec 11 04:21 PM
TURNER ANDREW LNon-Executive ChairmanDec 10Sale38.2210,001382,2425,000Dec 11 04:12 PM